Fortress Biotech Inc (FBIO)
1.73
-0.03
(-1.70%)
USD |
NASDAQ |
May 15, 14:52
Fortress Biotech Cash from Investing (Quarterly): -0.063M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.063M |
| September 30, 2023 | 4.999M |
| June 30, 2023 | -2.039M |
| March 31, 2023 | -5.00M |
| December 31, 2022 | -0.391M |
| September 30, 2022 | -0.893M |
| June 30, 2022 | -0.307M |
| March 31, 2022 | -21.34M |
| December 31, 2021 | 53.35M |
| September 30, 2021 | -7.541M |
| June 30, 2021 | -4.84M |
| March 31, 2021 | -0.458M |
| December 31, 2020 | -1.567M |
| September 30, 2020 | -2.758M |
| June 30, 2020 | -1.063M |
| March 31, 2020 | -1.776M |
| December 31, 2019 | 0.31M |
| September 30, 2019 | -3.75M |
| June 30, 2019 | -0.611M |
| March 31, 2019 | 24.15M |
| December 31, 2018 | 13.52M |
| September 30, 2018 | 9.331M |
| June 30, 2018 | -2.189M |
| March 31, 2018 | -1.84M |
| December 31, 2017 | 5.777M |
| Date | Value |
|---|---|
| September 30, 2017 | -24.84M |
| June 30, 2017 | -20.22M |
| March 31, 2017 | -0.942M |
| December 31, 2016 | -1.305M |
| September 30, 2016 | 2.166M |
| June 30, 2016 | -4.218M |
| March 31, 2016 | -2.703M |
| December 31, 2015 | 39.22M |
| September 30, 2015 | -21.30M |
| June 30, 2015 | -1.749M |
| March 31, 2015 | -8.287M |
| December 31, 2014 | -22.68M |
| September 30, 2014 | -0.05M |
| June 30, 2014 | -0.295M |
| March 31, 2014 | -0.25M |
| December 31, 2013 | -0.001M |
| September 30, 2013 | 0.079M |
| June 30, 2013 | -0.264M |
| March 31, 2013 | -0.002M |
| December 31, 2012 | -0.279M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-21.34M
Minimum
Mar 2022
53.35M
Maximum
Dec 2021
0.2246M
Average
-1.063M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Journey Medical Corp | 0.00 |
| Avenue Therapeutics Inc | 0.00 |
| Mustang Bio Inc | -0.03M |
| Checkpoint Therapeutics Inc | -- |
| Viking Therapeutics Inc | -459.79M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.94M |
| Cash from Financing (Quarterly) | 43.62M |
| Free Cash Flow | -136.32M |
| Free Cash Flow Per Share (Quarterly) | -3.252 |
| Free Cash Flow to Equity (Quarterly) | -50.06M |
| Free Cash Flow to Firm (Quarterly) | -33.63M |
| Free Cash Flow Yield | -972.1% |